N. Rovina (Athens, Greece), A. Johannessen (Bergen, Norway)
Characteristics of medication errors among respiratory drugs within the Food and Drug Administration’s Adverse Event Reporting System V. Pera (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), J. Van Der Lei (Rotterdam, Netherlands), J. Kors (Rotterdam, Netherlands), R. Parry (Rotterdam, Netherlands), E. Van Mulligen (Rotterdam, Netherlands), M. De Wilde (Rotterdam, Netherlands), G. Brusselle (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), K. Verhamme (Rotterdam, Netherlands)
| |
Programmatic advantage of cost-effective and highly sensitive rapid COVID-19 diagnostic with two-step screening strategy for airport quarantine in Bangladesh F. Zaman (Dhaka, Bangladesh), M. Asaduzzaman (Oslo, Norway)
| |
Spatial assessment of disease surveillance during the first wave of the COVID-19 pandemic F. Tydeman (London, United Kingdom), K. Kavanagh (Glasgow, United Kingdom), C. Robertson (Glasgow, United Kingdom)
| |
Incidence of dyspnea and hyperventilation syndrome after COVID-19 W. MADI (Gabes, Tunisia), S. Mejdoub Fehri (Gabes, Tunisia), R. Sellami (Gabes, Tunisia), A. Eleuch (Gabes, Tunisia), R. Ammar (Gabes, Tunisia), I. Ketata (Gabes, Tunisia), H. Kwas (Gabes, Tunisia)
| |
Tuberculosis in healthcare workers of Ukraine S. Zaikov (Kyiv, Ukraine), A. Bogomolov (Vinnytsya, Ukraine), O. Litvinyuk (Vinnytsya, Ukraine)
| |
Characterisation and burden of eosinophilic granulomatosis with polyangiitis: a European retrospective study R. Jakes (London, United Kingdom), N. Kwon (Brentford, United Kingdom), L. Huynh (Boston, United States), J. Hwee (Mississauga, Canada), L. Baylis (Durham, United States), R. Alfonso-Cristancho (Collegeville, United States), S. Du (Boston, United States), A. Khanal (Boston, United States), M. Duh (Boston, United States)
| |
Reference values for respiratory impedance in adult men and women: data from the Austrian LEAD Study. C. Valach (Vienna, Austria), E. Wouters (Vienna, Austria), A. Ofenheimer (Vienna, Austria), P. Puchhammer (Vienna, Austria), P. Pompilio (Milan, Italy), A. Gobbi (Milan, Italy), M. Breyer (Vienna, Austria), S. Hartl (Vienna, Austria), O. Burghuber (Vienna, Austria), R. Breyer-Kohansal (Vienna, Austria)
| |
Respiratory symptoms and lung function in Women N. Hammache (Tizi-Ouzou, Algeria), S. Nafti (Algiers, Algeria), R. Abdellaziz (Tizi-Ouzou, Algeria)
| |
Association of tuberculosis infection with asthma in a european multinational cohort S. Gyawali (Bergen, Norway), J. López Cervantes (Bergen, Norway), T. Mustafa (Bergen, Norway), C. Svanes (Bergen, Norway), R. Shigdel (Bergen, Norway)
| |
Treatment with oral anticoagulants and risk of mortality in COVID-19 patients S. Altaraihi (Hellerup, Denmark), P. Kamstrup (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Jensen (Hellerup, Copenhagen, Denmark)
| |
Associations for food and carbohydrate intake with asthma in young Chinese adults from Singapore and Malaysia Q. Wong (Singapore, Singapore), J. Lim (Singapore, Singapore), J. Ng (Singapore, Singapore), P. Malipeddi (Singapore, Singapore), W. Teo (Singapore, Singapore), Y. Lim (Singapore, Singapore), Y. Wong (Selangor, Malaysia), K. Teh (Selangor, Malaysia), S. Rawanan Shah (Selangor, Malaysia), K. Reginald (Selangor, Malaysia), Y. Say (Selangor, Malaysia), S. Matta (Singapore, Singapore), Y. Sio (Singapore, Singapore), F. Chew (Singapore, Singapore)
| |
The many diseases associated with dyspnoea: a MeSH term and semantic analysis of the PubMed literature T. Cross (Sydney, Australia), S. Morris (Sydney, Australia), H. Lewthwaite (Newcastle, Australia)
| |
Association between candidate gene polymorphisms and total IgE in adult subjects with asthma: preliminary results from the GEIRD study V. Lando (Verona, Italy), L. Calciano (Verona, Italy), G. Malerba (Verona, Italy), C. Bombieri (Verona, Italy), M. Ferrari (Verona, Italy), N. Murgia (Perugia, Italy), M. Nicolis (Verona, Italy), M. Olivieri (Verona, Italy), S. Accordini (Verona, Italy)
| |
Adipokines in restrictive spirometric pattern H. Amman (Umeå, Sweden), S. Söderberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden), H. Backman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), U. Nilsson (Umeå, Sweden)
| |
Second primary lung cancer, an increasingly recognised entity in cancer survivors. H. Kalsi (London, United Kingdom), D. Campbell (London, United Kingdom), N. Low (London, United Kingdom), R. Lee (London, United Kingdom)
| |
Bronchiectasis and pneumonia-hospitalization risk: The impact of social distancing measures – A cohort study V. Rømer (Copenhagen, Denmark), M. Fosgaard (Copenhagen, Denmark), P. Sivapalan (Copenhagen, Denmark), J. Eklöf (Copenhagen, Denmark), M. Saeed (Copenhagen, Denmark), L. Lindhardt Tønnesen (Copenhagen, Denmark), A. Jordan (Copenhagen, Denmark), R. Sørensen (Copenhagen, Denmark), T. Gissel (Copenhagen, Denmark), U. Weinreich (Copenhagen, Denmark), S. Johansson (Copenhagen, Denmark), J. Stæhr Jensen (Copenhagen, Denmark)
| |
Late Breaking Abstract - Real world endotype stability and exacerbation rates in T2low asthma A. Viinanen (Turku, Finland), J. Aakko (Espoo, Finland), G. Telg (Stockholm, Sweden), K. Nieminen (Espoo, Finland), M. Lassenius (Espoo, Finland), H. Kankaanranta (Tampere, Finland), L. Lehtimäki (Tampere, Finland)
| |
Late Breaking Abstract - Race/ethnic, social, environmental, and genetic correlates to lung function decline: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study R. Barr (New York, United States), A. Elmaleh-Sachs (New York, United States), D. Malinsky (New York, United States), P. Balte (New York, United States), N. Allen (Chicago, United States), A. Baugh (San Francisco, United States), A. Bertoni (Winston-Salem, United States), J. Hirsch (Philadelphia, United States), E. Hoffman (Iowa City, United States), J. Kaufman (Seattle, United States), A. Manichaikul (Charlottesville, United States), E. Oeslner (New York, United States), J. Pankow (Minneapolis, United States), W. Post (Baltimore, United States), T. Pottinger (New York, United States), S. Rich (Charlottesville, United States), B. Smith (New York, United States), K. Watson (Los Angeles, United States)
| |
Late Breaking Abstract - a1-Antitrypsin deficiency associated with increased risk of heart failure in two large populations S. Voss Winther (Køge, Denmark), E. Landt (Køge, Denmark), B. Nordestgaard (Herlev, Denmark), N. Seersholm (Gentofte, Denmark), M. Dahl (Køge, Denmark)
| |